Our Health Services

Our clinic provides a variety of in-office procedures including ultrasound, IUD and contraceptive implant insertions, colposcopy, LEEP, sonohysterograms, NovaSure™ endometrial ablation and treatment for vaginal atrophy and painful intercourse with the MonaLisa Touch Fractional CO₂ Laser.

Our medical providers are often able to accommodate same-day and same week appointments, and evening appointments are available one day a week.

All of our patients are afforded easy access to our clinicians by phone to respond to questions and concerns, in most cases the same day the call is placed.

We offer complete laboratory evaluation including basic blood tests, Clomid challenge test, and other endocrine tests as needed. We can also refer you for semen analysis for evaluation of male infertility, and hysterosalpingogram to make sure your fallopian tubes are open and to help you interpret the results of these tests.

If the time comes that you need to work with a fertility specialist, we will be happy to refer you to one of the outstanding practices in the area.

The MonaLisa Touch® procedure is a unique treatment that uses a medical laser that delivers controlled energy to the vaginal tissue so cells make more collagen.  As a result, the vaginal tissue becomes healthier.  This is an effective treatment for genitourinary syndrome of menopause including pain with sexual intercourse, vaginal dryness, frequent vaginal infections, lichen sclerosus, frequent urinary tract infections, urinary incontinence and other symptoms associated with changes in vulvovaginal tissue.  MonaLisa Touch® is an excellent alternative for women who cannot or choose not to use hormones to treat these symptoms.

This procedure is

1. A virtually painless, in-office treatment
2. Performed without requiring anesthesia
3. Quick (it takes <5 minutes), resulting in virtually no down time
4. Able to yield results after the first treatment (3 treatments are recommended)

Anyone who is sexually active, even without intercourse, can get HPV. Many people with HPV don’t have any signs or symptoms and they can pass the virus on without even knowing it. It is estimated that 80% of women will have contracted at least one of the high risk genital HPV types by age 50 although most people get HPV within the first 2 to 3 years of becoming sexually active.

There are over 100 types of HPV, about 30 of which infect the genital tract of both men and women. Some of these are called “low risk” because they cause genital warts and benign changes to the cervix. Others are called “high risk” because they are capable of causing cancer and precancerous changes that could turn into cancer in the future.  GARDASIL-9® helps protect against the 9 most common genital strains of HPV and includes protection against the 4 types of low risk HPV that cause 90% of genital warts and the 7 types of high risk HPV that cause 90% of cervical cancers. The vaccine will not protect you against types to which you have already been exposed. It will also not protect you against diseases due to HPV types not included in the vaccine. Therefore, it is important to continue getting your regular Pap tests.

GARDASIL-9® is recommended for girls and women ages 9 to 26 and like all vaccines, is most effective when given prior to exposure to the virus, which is by definition prior to first sexual activity. However, everyone in this age group is eligible for the vaccine whether or not they have ever been sexually active and regardless of whether they have ever had an HPV-related disease in the past. It is not recommended for pregnant women. GARDASIL-9® is given as a series of 2 or 3 injections.

Between 5 and 10 percent of all U.S. women complain to their doctors about AUB, which affects more than 10 million annually. AUB is defined as menstrual loss of more than 80 mL. This translates to menses that continues for more than seven days or the use of more than 10 pads or tampons per day. It is most commonly associated with perimenopause.

AUB can cause chronic anemia, pelvic pain and cramping. The condition also severely impacts quality of life by disrupting work, social functioning and family life.

AUB can have hormonal or non-hormonal causes. Uterine fibroids, or myomas, are a common non-hormonal cause. Clinically, there are three main types of myomas, classified according to their location in the uterus:

• Intramural myomas grow within the uterine wall.
• Subserosal myomas develop in the outer portion of the uterus.
• Submucosal myomas grow just under the lining of the uterine cavity and near the endometrial cavity.

It’s this last group of myomas, the submucosal, that have the most effect on AUB. Because of their location on the endometrium, these myomas place pressure on the uterine lining that builds with each menstrual cycle. This, in turn, can cause heavy bleeding. Even very small submucosal myomas may cause very heavy bleeding.

Endometrial polyps are another non-hormonal cause of AUB. These hyperplastic overgrowths of glands and stroma form a mushroom-like fold that projects into the uterine cavity. They can be single or multiple growths.

Hysteroscopic fibroid removal is one of the most effective treatment option, delivering several advantages over conventional techniques for the removal of submucosal myomas and endometrial polyps.

Approved by the FDA in 2004, Hysteroscopic fibroid removal uses a probe with a “uterine shaver.” Once placed inside the uterine cavity, the device shaves off and immediately suctions out any excised tissue that might impair visibility. The ability to remove and instantly suction out tissue fragments means the hysteroscope and fibroid removal instrument are inserted only once, for initial entry. This is a huge advantage from both the physician’s and the patient’s point of view.

In addition, in 2018 we are proud to offer in-office uterine polyp removals.  For the patient, this means there is no need for general anesthesia and a quicker recovery.